HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hinako Tsunekawa Selected Research

Infliximab (Remicade)

7/2011Long-term remission of ocular and extraocular manifestations in Behçet's disease using infliximab.
5/2011Cataract Surgery in Behçet's Disease Patients One Week after Infliximab Administration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hinako Tsunekawa Research Topics

Disease

1Uveitis
07/2011
1Cataract (Cataracts)
05/2011
1Posterior Uveitis
12/2010

Drug/Important Bio-Agent (IBA)

2Infliximab (Remicade)FDA Link
07/2011 - 05/2011
1AntibodiesIBA
07/2011
1Ophthalmic Solutions (Eye Drops)IBA
05/2011
1TabletsIBA
05/2011
1Levofloxacin (Levaquin)FDA Link
05/2011
1Anti-Bacterial Agents (Antibiotics)IBA
05/2011
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2010

Therapy/Procedure

1Therapeutics
05/2011
1Phacoemulsification
05/2011
1Intraocular Lens Implantation
05/2011